Carolyn F Sidor, Age 7681414 Alexander, Chapel Hill, NC 27517

Carolyn Sidor Phones & Addresses

81414 Alexander, Chapel Hill, NC 27517 (919) 932-2666

Mill Spring, NC

Pinehurst, NC

North Potomac, MD

Durham, NC

Wilmington, DE

Work

Company: University of North Carolina Hospital Address: 101 Manning Drive, Chapel Hill, NC 27514

Education

School / High School: Thomas Jefferson University 1982

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Hematology, 1988

Mentions for Carolyn F Sidor

Career records & work history

Medicine Doctors

Carolyn Sidor Photo 1

Dr. Carolyn F Sidor, Chapel Hill NC - MD (Doctor of Medicine)

Specialties:
Hematology
Medical Oncology
Oncology
Address:
101 Manning Dr, Chapel Hill, NC 27514
(919) 966-4996 (Phone) (919) 843-5515 (Fax)
81414 Alexander, Chapel Hill, NC 27517
(919) 932-2666 (Phone) (919) 960-7647 (Fax)
Certifications:
Hematology, 1988
Internal Medicine, 1985
Medical Oncology, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
101 Manning Dr, Chapel Hill, NC 27514
81414 Alexander, Chapel Hill, NC 27517
University of North Carolina Hospital
101 Manning Drive, Chapel Hill, NC 27514
Education:
Medical School
Thomas Jefferson University
Graduated: 1982
Medical School
Med Ctr Delaware
Graduated: 1982
Medical School
Main Line Hospital-Lankenau
Graduated: 1982
Carolyn Sidor Photo 2

Carolyn Fowler Sidor, Chapel Hill NC

Specialties:
Internal Medicine
Hematology
Medical Oncology
Hematology & Oncology
Work:
Unc Physicans And Associates
6013 Farrington Rd, Chapel Hill, NC 27517
Education:
Thomas Jefferson University (1982)

License Records

Carolyn F Sidor

Licenses:
License #: MT014133T - Expired
Category: Medicine
Type: Graduate Medical Trainee

Carolyn Fowler Sidor

Address:
Chapel Hill, NC 27517
Licenses:
License #: MD033503E - Expired
Category: Medicine
Type: Medical Physician and Surgeon

Resumes & CV records

Resumes

Carolyn Sidor Photo 13

Carolyn F Sidor

Location:
300 George St, New Haven, CT 06511
Industry:
Biotechnology
Work:
Kolltan Pharmaceuticals, Inc. Sep 2013 - Jul 2015
Chief Medical Officer
Entremed Jun 2001 - May 2012
Vice President and Chief Marketing Officer
Cato Research 1993 - 2001
Chief Marketing Officer
Education:
University of Delaware 1972 - 1974
Master of Business Administration, Masters, Marketing
Syracuse University
Bachelors, Bachelor of Science, Biochemistry
Thomas Jefferson University
Doctor of Medicine, Doctorates, Medicine
Skills:
Clinical Trials, Regulatory Submissions, Oncology, Biopharmaceuticals, Clinical Development, Regulatory Affairs, Cro, Ctms, Regultory Submissions, Hematology, Vaccines, Infectious Diseases, Edc, Fda, Clinical Data Management, Gcp, Gmp, Medical Writing, Technology Transfer, Therapeutic Areas, Sop, Commercialization, Drug Discovery, Early Clinical Trials
Certifications:
Senior Rules Official
Carolyn Sidor Photo 14

Carolyn Sidor

Publications & IP owners

Us Patents

Method Of Administering Anti-Angiogenic Agents And A Method Of Treating Disease Using Same

US Patent:
2006011, Jun 1, 2006
Filed:
Nov 29, 2005
Appl. No.:
11/288989
Inventors:
William Fogler - Rockville MD, US
Carolyn Sidor - Chapel Hill NC, US
Anthony Treston - Rockville MD, US
Kirk Volker - North Potomac MD, US
International Classification:
A61K 31/56
US Classification:
514182000
Abstract:
A method of administering an anti-angiogenic agent to a human or an animal comprising administering the anti-angiogenic agent such that a plasma concentration of the anti-angiogenic agent in the human or animal is substantially continuously maintained above 1 ng/mL.

Anti-Angiogenic Activity Of 2-Methoxyestradiol In Combination With Anti-Cancer Agents

US Patent:
2007018, Aug 9, 2007
Filed:
Nov 14, 2006
Appl. No.:
11/599997
Inventors:
Stacy Plum - Arlington VA, US
Steven Strawn - Arlington VA, US
Theresa LaVallee - Rockville MD, US
Carolyn Sidor - Chapel Hill NC, US
William Fogler - Rockville MD, US
Anthony Treston - Rockville MD, US
International Classification:
A61K 31/56
US Classification:
514182000, 514506000
Abstract:
The present invention relates generally to methods and compositions of treating disease characterized by abnormal cell proliferation and/or abnormal or undesirable angiogenesis by administering antiangiogenic agents in combination with chemotherapeutic agents. More specifically, the present invention relates to a methods and compositions of treating diseases characterized by abnormal cell proliferation and/or abnormal or undesirable angiogenesis by administering 2-methoxyestradiol, in combination with chemotherapeutic agents.

Disease Modifying Anti-Arthritic Activity Of 2-Methoxyestradiol

US Patent:
2007023, Oct 4, 2007
Filed:
Mar 20, 2007
Appl. No.:
11/726361
Inventors:
William Fogler - Rockville MD, US
Stacy Plum - Arlington VA, US
Carolyn Sidor - Chapel Hill NC, US
International Classification:
A61K 33/24
A61K 31/66
A61K 31/616
A61K 31/56
A61K 31/525
A61K 31/519
A61K 31/59
A61K 31/192
A61K 31/415
A61K 31/365
US Classification:
424649000, 514182000, 514171000, 514251000, 514406000, 514471000, 514159000, 514165000, 514102000, 514570000, 514569000, 514109000, 514262100, 514546000, 514167000
Abstract:
The present invention relates a composition for treating rheumatic diseases. The composition comprises a compound having the formula wherein Ris selected from —OCH, —OCHCH, —CH, —CHCH, —CCCH, —CHCH—CH, or CH—CHCH; and one or more anti-rheumatic agents. A method of using the composition for treating rheumatic diseases in humans and animals is also disclosed.

Anti-Angiogenic Activity Of 2-Methoxyestradiol Analogs In Combination With Anti-Cancer Agents

US Patent:
2010011, May 6, 2010
Filed:
Oct 31, 2008
Appl. No.:
12/262318
Inventors:
THERESA LAVALLEE - Rockville MD, US
WILLIAM E. FOGLER - Rockville MD, US
CAROLYN F. SIDOR - Chapel Hill NC, US
International Classification:
A61K 31/565
A61P 35/00
US Classification:
514171
Abstract:
The present invention relates generally to methods and compositions for treating diseases characterized by abnormal cell proliferation and/or abnormal or undesirable angiogenesis by administering antiangiogenic agents in combination with anti-cancer agents. More specifically, the present invention relates to methods and compositions for treating diseases characterized by abnormal cell proliferation and/or abnormal or undesirable angiogenesis by administering 2-methoxyestradiol analogs, in combination with anti-cancer agents.

Uses Of Anti-Her3 Antibodies For Treating Cancer

US Patent:
2018036, Dec 20, 2018
Filed:
Aug 24, 2018
Appl. No.:
16/111724
Inventors:
- Hamtpon NJ, US
Carolyn Fowler SIDOR - Chapel Hill NC, US
Diego ALVARADO - Madison CT, US
Assignee:
Celldex Therapeutics, Inc. - Hampton NJ
International Classification:
C07C 211/21
C12N 15/85
A61K 9/127
A61K 9/50
A61K 38/47
A61K 38/18
Abstract:
Provided herein are methods of treating cancer comprising administering antibodies and antigen-binding fragments thereof that bind the extracellular domain of the HER3 receptor and inhibit various HER3 receptor related functions via ligand-dependent and/or ligand-independent mechanisms, and dosing regimens for related monotherapies and combination therapies.

Uses Of Anti-Her3 Antibodies For Treating Cancer

US Patent:
2017019, Jul 6, 2017
Filed:
Sep 10, 2015
Appl. No.:
15/510574
Inventors:
Theresa Marie LAVALLEE - Rockville MD, US
Carolyn Fowler SIDOR - Chapel Hill NC, US
Diego ALVARADO - Madison CT, US
- Road Town, VG
Assignee:
BULLDOG PHARMACEUTICALS, INC. - Road Town
International Classification:
C07K 16/32
A61K 39/395
A61K 31/519
A61K 51/10
C07K 16/28
A61K 31/517
A61K 31/506
C07K 16/30
A61K 31/437
Abstract:
Provided herein are methods of treating cancer comprising administering antibodies and antigen-binding fragments thereof that bind the extracellular domain of the HER3 receptor and inhibit various HER3 receptor related functions via ligand-dependent and/or ligand-independent mechanisms, and dosing regimens for related monotherapies and combination therapies.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.